Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Foreman

Showing results (251-260 of 326) with videos related to

Pageof 33
Sort By:
Neuro-Oncology|September 28, 2011
High expression of BMP pathway genes distinguishes a subset of atypical teratoid/rhabdoid tumors associated with shorter survivalDiane K Birks, Andrew M Donson, Purvi R Patel, et al.
Journal of Neuropathology and Experimental Neurology|March 22, 2021
NTRK Fusions Can Co-Occur With H3K27M Mutations and May Define Druggable Subclones Within Diffuse Midline GliomasNathan A Dahl, Andrew M Donson, Bridget Sanford, et al.
Pediatric Blood & Cancer|July 3, 2020
A retrospective analysis of recurrent pediatric ependymoma reveals extremely poor survival and ineffectiveness of current treatments across central nervous system locations and molecular subgroupsTimothy A Ritzmann, Hazel A Rogers, Simon M L Paine, et al.
Journal of the American Academy of Dermatology|February 22, 2023
Tumor-infiltrating lymphocytes as a predictive biomarker of cutaneous immune-related adverse events after immune checkpoint blockade in patients with advanced melanomaMichael R Stephens, Maria S Asdourian, Ted V Jacoby, et al.
Brain Pathology (Zurich, Switzerland)|November 19, 2013
Pediatric brainstem gangliogliomas show BRAF(V600E) mutation in a high percentage of casesAndrew M Donson, Bette K Kleinschmidt-DeMasters, Dara L Aisner, et al.
Cancer Discovery|May 15, 2014
Autophagy inhibition improves chemosensitivity in BRAF(V600E) brain tumorsJean M Mulcahy Levy, Joshua C Thompson, Andrea M Griesinger, et al.
Neuro-Oncology|September 3, 2021
A novel PLK1 inhibitor onvansertib effectively sensitizes MYC-driven medulloblastoma to radiotherapyDong Wang, Bethany Veo, Angela Pierce, et al.
Neuro-Oncology|March 7, 2018
Multiplexed immunofluorescence reveals potential PD-1/PD-L1 pathway vulnerabilities in craniopharyngiomaShannon Coy, Rumana Rashid, Jia-Ren Lin, et al.
Journal of Neuropathology and Experimental Neurology|September 3, 2017
Characterization of 2 Novel Ependymoma Cell Lines With Chromosome 1q Gain Derived From Posterior Fossa Tumors of ChildhoodVladimir Amani, Andrew M Donson, Seth C Lummus, et al.
Molecular Cancer Research : MCR|February 17, 2025
SIRT2 Regulates the SMARCB1 Loss-Driven Differentiation Block in ATRTIrina Alimova, Dong Wang, John DeSisto, et al.
Pageof 33

Showing results (251-260 of 326) with videos related to

Sort By:
Pageof 33
Neuro-Oncology|September 28, 2011
High expression of BMP pathway genes distinguishes a subset of atypical teratoid/rhabdoid tumors associated with shorter survivalDiane K Birks, Andrew M Donson, Purvi R Patel, et al.
Journal of Neuropathology and Experimental Neurology|March 22, 2021
NTRK Fusions Can Co-Occur With H3K27M Mutations and May Define Druggable Subclones Within Diffuse Midline GliomasNathan A Dahl, Andrew M Donson, Bridget Sanford, et al.
Pediatric Blood & Cancer|July 3, 2020
A retrospective analysis of recurrent pediatric ependymoma reveals extremely poor survival and ineffectiveness of current treatments across central nervous system locations and molecular subgroupsTimothy A Ritzmann, Hazel A Rogers, Simon M L Paine, et al.
Journal of the American Academy of Dermatology|February 22, 2023
Tumor-infiltrating lymphocytes as a predictive biomarker of cutaneous immune-related adverse events after immune checkpoint blockade in patients with advanced melanomaMichael R Stephens, Maria S Asdourian, Ted V Jacoby, et al.
Brain Pathology (Zurich, Switzerland)|November 19, 2013
Pediatric brainstem gangliogliomas show BRAF(V600E) mutation in a high percentage of casesAndrew M Donson, Bette K Kleinschmidt-DeMasters, Dara L Aisner, et al.
Cancer Discovery|May 15, 2014
Autophagy inhibition improves chemosensitivity in BRAF(V600E) brain tumorsJean M Mulcahy Levy, Joshua C Thompson, Andrea M Griesinger, et al.
Neuro-Oncology|September 3, 2021
A novel PLK1 inhibitor onvansertib effectively sensitizes MYC-driven medulloblastoma to radiotherapyDong Wang, Bethany Veo, Angela Pierce, et al.
Neuro-Oncology|March 7, 2018
Multiplexed immunofluorescence reveals potential PD-1/PD-L1 pathway vulnerabilities in craniopharyngiomaShannon Coy, Rumana Rashid, Jia-Ren Lin, et al.
Journal of Neuropathology and Experimental Neurology|September 3, 2017
Characterization of 2 Novel Ependymoma Cell Lines With Chromosome 1q Gain Derived From Posterior Fossa Tumors of ChildhoodVladimir Amani, Andrew M Donson, Seth C Lummus, et al.
Molecular Cancer Research : MCR|February 17, 2025
SIRT2 Regulates the SMARCB1 Loss-Driven Differentiation Block in ATRTIrina Alimova, Dong Wang, John DeSisto, et al.
Pageof 33